Late luteal progesterone as a marker of implantation success rather than its determinant in modified natural cycle single euploid frozen embryo transfer: a prospective multicenter study
In modified natural cycle single euploid frozen embryo transfer, late-luteal progesterone levels on the day of the pregnancy test serve as a strong prognostic marker of implantation success rather than a causal determinant, whereas progesterone levels on the day of embryo transfer show no predictive value for reproductive outcomes.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the journey to create a new life through assisted reproduction, doctors often face a critical window of time known as the luteal phase. This is the period after an egg is released from the ovary and before a potential pregnancy is confirmed. During these days, the body naturally produces a hormone called progesterone, which acts like a gentle, essential fertilizer, preparing the lining of the uterus to receive and nurture an embryo. For years, the medical community has worried that if this hormone level is too low, the embryo will fail to take root, leading to a failed treatment. This concern has been so strong that in many fertility cycles, doctors routinely add extra progesterone to the patient's regimen, hoping to ensure the environment is perfect. However, a significant question has remained: does measuring this hormone tell us if a pregnancy will succeed, or does it simply tell us if a pregnancy has already begun?
A new study conducted across six fertility centers in Spain has looked closely at this question using a specific, modern approach. The researchers focused on patients undergoing a "modified natural cycle," a method where the body is allowed to release its own egg, but a small trigger is given to ensure the timing is right, followed by the transfer of a single, genetically healthy embryo. In this setting, the body still produces its own progesterone from the ovary, unlike other methods where the body's natural production is bypassed entirely. The team measured progesterone levels at two distinct moments: the day the embryo was placed in the uterus, and again about nine days later, when a blood test checks for the first signs of pregnancy. They wanted to know if the hormone level on the first day could predict the future, or if the level on the second day was the true indicator of success.
The results of this investigation offer a clear and somewhat surprising shift in how we might understand this biological process. When the researchers looked at the progesterone levels on the day the embryo was transferred, they found no difference between the women who went on to have a successful, ongoing pregnancy and those who did not. The hormone levels were essentially the same in both groups, hovering around 26 nanograms per milliliter. This measurement acted like a flat line, showing no ability to distinguish between success and failure. It suggests that as long as the initial environment is adequate, the specific number on that first day does not determine the outcome.
The story changed completely when the researchers looked at the second measurement, taken on the day the pregnancy test was performed. Here, a stark difference emerged. Women who had a viable pregnancy continuing to ten weeks had progesterone levels that were significantly higher, averaging around 34 nanograms per milliliter. In contrast, women whose pregnancies did not continue had levels that had dropped to an average of roughly 13 nanograms per milliliter. This single measurement proved to be a powerful predictor, correctly identifying the vast majority of successful pregnancies. The data showed that a level above 20.9 nanograms per milliliter on this specific day was a strong sign that the pregnancy was thriving, while levels below this threshold were a clear warning sign.
The most profound insight from this work is not just about the numbers, but about what those numbers actually mean. The researchers argue that the high progesterone levels seen in successful pregnancies are not the cause of the success, but rather the result of it. In a natural cycle, the ovary produces progesterone, but once an embryo implants and begins to grow, it sends out a chemical signal that tells the ovary to keep producing even more of this hormone. If the embryo fails to implant or is not viable, that signal never arrives, and the progesterone levels naturally begin to fall. Therefore, a low level of progesterone on the pregnancy test day is likely a symptom of a failed implantation, not the reason for it. It is the body reporting that the signal from the embryo was never received.
This distinction challenges a common practice in fertility care. In cycles where the body does not produce its own progesterone, doctors often give extra hormone supplements if levels drop, hoping to "rescue" the pregnancy. However, in the natural cycles studied here, where the body is still doing the work, the data suggests that adding more progesterone after a failed implantation signal would be like trying to water a plant that has already stopped growing; the fertilizer cannot fix the root problem. The study concludes that in these specific natural cycles, the late-stage progesterone level is a marker of what has already happened, not a lever that can be pulled to change the outcome. While this does not mean progesterone is unimportant, it suggests that for this group of patients, the hormone level on the pregnancy test day is a mirror reflecting the success of the implantation, rather than the engine driving it.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.